Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Inv. presentation
Appointed director
CC transcript
|
|
Neurotrope, Inc. (NTRP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/29/2021 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 0% stake in Neurotrope, Inc. |
| 12/07/2020 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur... |
| 12/02/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/25/2020 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 11/24/2020 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 11/24/2020 |
8-K
| Other Events Interactive Data |
| 11/20/2020 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 11/20/2020 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 11/09/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 09/30/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/30/2020 |
8-K
| Quarterly results |
| 09/30/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/30/2020 |
8-K
| Quarterly results |
| 08/10/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 07/29/2020 |
8-K
| Quarterly results |
| 07/24/2020 |
8-K
| Quarterly results |
| 07/24/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 07/23/2020 |
8-K
| Quarterly results |
| 07/23/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/12/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
| 05/28/2020 |
8-K
| Conference call transcript |
| 05/28/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 05/18/2020 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits|
Docs:
|
"Agreement and Plan of Merger and Reorganization, by and among Petros, Neurotrope, Merger Sub 1, Merger Sub 2 and Metuchen",
"Form of Neurotrope Voting Agreement, by and between Metuchen and certain stockholders of Neurotrope",
"Form of Metuchen Voting Agreement, by and between Neurotrope and certain unitholders of Metuchen",
"Form of Lock-Up Agreement, by and between Petros, Neurotrope, Metuchen and certain securityholders of Neurotrope and Metuchen",
"Consent of EisnerAmper LLP, Metuchen’ s independent registered public accounting firm",
"Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men’ s Health Company",
"“Metuchen Business” section excerpt",
"“Metuchen Management’ s Disclosure and Analysis of Financial Condition and Results of Operations” section excerpt",
"“Risk Factors” section excerpt",
"“Fairness Opinion of Gemini Partners LLC” section excerpt" |
|
| 05/18/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 05/11/2020 |
8-K
| Other Events |
| 04/27/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/24/2020 |
424B2
| Form 424B2 - Prospectus [Rule 424(b)(2)]: |
| 04/17/2020 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 03/13/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 02/27/2020 |
8-K
| Quarterly results |
| 02/26/2020 |
8-K
| Quarterly results |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/30/2020 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Neurotrope, Inc. |
|
|
|